JP Morgan Chase’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.15M Buy
117,159
+39,461
+51% +$2.7M ﹤0.01% 2868
2025
Q4
$4.6M Sell
77,698
-48,382
-38% -$2.63M ﹤0.01% 3388
2025
Q3
$6.96M Buy
126,080
+50,498
+67% +$2.63M ﹤0.01% 3066
2025
Q2
$3.26M Sell
75,582
-4,030
-5% -$155K ﹤0.01% 3535
2025
Q1
$3.15M Sell
79,612
-106,644
-57% -$4.72M ﹤0.01% 3534
2024
Q4
$7.59M Buy
186,256
+68,675
+58% +$2.86M ﹤0.01% 2967
2024
Q3
$4.59M Buy
117,581
+23,460
+25% +$934K ﹤0.01% 3281
2024
Q2
$4.11M Sell
94,121
-137,814
-59% -$6.66M ﹤0.01% 3185
2024
Q1
$11.1M Buy
231,935
+95,087
+69% +$4.27M ﹤0.01% 2385
2023
Q4
$6.46M Sell
136,848
-18,011
-12% -$748K ﹤0.01% 2859
2023
Q3
$7.37M Sell
154,859
-28,811
-16% -$1.57M ﹤0.01% 2530
2023
Q2
$10.7M Sell
183,670
-35,091
-16% -$2.1M ﹤0.01% 2238
2023
Q1
$15.6M Buy
218,761
+2,889
+1% +$229K ﹤0.01% 1868
2022
Q4
$15.2M Buy
215,872
+5,342
+3% +$377K ﹤0.01% 1881
2022
Q3
$12.8M Sell
210,530
-5,999
-3% -$402K ﹤0.01% 1963
2022
Q2
$13.7M Sell
216,529
-648
-0.3% -$42.2K ﹤0.01% 1918
2022
Q1
$13.9M Sell
217,177
-43,498
-17% -$2.91M ﹤0.01% 2069
2021
Q4
$18.7M Buy
260,675
+24,875
+11% +$1.89M ﹤0.01% 1885
2021
Q3
$16.8M Sell
235,800
-4,684
-2% -$369K ﹤0.01% 1905
2021
Q2
$19.6M Sell
240,484
-38,613
-14% -$3.11M ﹤0.01% 1866
2021
Q1
$21.1M Buy
279,097
+32,320
+13% +$2.35M ﹤0.01% 1725
2020
Q4
$18.7M Buy
246,777
+132,061
+115% +$8.6M ﹤0.01% 1672
2020
Q3
$5.68M Buy
114,716
+35,002
+44% +$1.98M ﹤0.01% 2463
2020
Q2
$4.19M Buy
79,714
+20,418
+34% +$969K ﹤0.01% 2591
2020
Q1
$2.09M Sell
59,296
-102,325
-63% -$5.98M ﹤0.01% 2938
2019
Q4
$14.1M Buy
161,621
+10,250
+7% +$896K ﹤0.01% 1837
2019
Q3
$12.8M Buy
151,371
+90,181
+147% +$8.03M ﹤0.01% 1937
2019
Q2
$6.14M Sell
61,190
-52,547
-46% -$5.28M ﹤0.01% 2478
2019
Q1
$12M Buy
113,737
+64,821
+133% +$6.51M ﹤0.01% 1891
2018
Q4
$4.09M Sell
48,916
-12,097
-20% -$1.1M ﹤0.01% 2736
2018
Q3
$6.22M Sell
61,013
-55,884
-48% -$5.39M ﹤0.01% 2571
2018
Q2
$9.45M Sell
116,897
-30,766
-21% -$2.45M ﹤0.01% 2190
2018
Q1
$10.9M Sell
147,663
-15,505
-10% -$1.16M ﹤0.01% 1968
2017
Q4
$11.5M Buy
163,168
+41,564
+34% +$3M ﹤0.01% 2011
2017
Q3
$7.6M Buy
121,604
+16,052
+15% +$951K ﹤0.01% 2213
2017
Q2
$6.06M Sell
105,552
-64,301
-38% -$3.78M ﹤0.01% 2350
2017
Q1
$10.3M Sell
169,853
-42,205
-20% -$2.39M ﹤0.01% 1915
2016
Q4
$11.6M Buy
212,058
+114,819
+118% +$5.51M ﹤0.01% 1819
2016
Q3
$4.48M Buy
97,239
+39,590
+69% +$1.67M ﹤0.01% 2327
2016
Q2
$1.96M Buy
+57,649
New +$1.8M ﹤0.01% 2815

Other funds holding NGVT

JP Morgan Chase's NGVT Position: Q1 2026 in Review

JP Morgan Chase increased its Ingevity (NGVT) stake by 51% in Q1 2026, buying an estimated $2.7M and bringing the position to 117,159 shares worth $8.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2868.

JP Morgan Chase first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $21.1M in Q1 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • JP Morgan Chase held 117,159 shares of Ingevity worth $8.15M as of Q1 2026.
  • JP Morgan Chase bought 39,461 Ingevity shares in Q1 2026, an estimated $2.7M.
  • Ingevity made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2868 holding.
  • JP Morgan Chase first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
  • JP Morgan Chase's Ingevity position peaked at $21.1M in Q1 2021.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.